Platelet receptor recognition and cross-talk in collagen-induced activation of platelets

Journal of Thrombosis and Haemostasis

Volumn 5, Issue SUPPL. 1, 2007, Pages 220-229

  Farndale, R W ^a   Slatter, D A ^a   Siljander, P R M ^b   Jarvis, G E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Fibril; Glycoprotein VI; Integrin 2 1; Lipid rafts; von Willebrand factor

Indexed keywords

COLLAGEN; COLLAGEN FIBER; COLLAGEN TYPE 3; FC RECEPTOR; GLYCOPROTEIN VI; THROMBOCYTE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 2; VON WILLEBRAND FACTOR;

BINDING AFFINITY; BINDING SITE; CELL MEMBRANE; CRYSTAL STRUCTURE; GENE MAPPING; HUMAN; LIPID RAFT; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE;

BLOOD PLATELETS; COLLAGEN; PLATELET ACTIVATION; RECEPTOR CROSS-TALK; RECEPTORS, CELL SURFACE;

EID: 34250730360     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02521.x     Document Type: Review

References (116)

1. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-34.
2. Diaz-Ricart M, Tandon NN, Gomez-Ortiz G, Carretero M, Escolar G, Ordinas A, Jamieson GA. Antibodies to CD36 (GPIV) inhibit platelet adhesion to subendothelial surfaces under flow conditions. Arterioscler Thromb Vasc Biol 1996; 16: 883-8.
3. Maurice P, Waeckel L, Pires V, Sonnet P, Lemesle M, Arbeille B, Vassy J, Rochette J, Legrand C, Fauvel-Lafeve F. The platelet receptor for type III collagen (TIIICBP) is present in platelet membrane lipid microdomains (rafts). Histochem Cell Biol 2006; 125: 407-17.
4. Zhu J, Cole F, Woo-Rasberry V, Fang XR, Chiang TM. Type I and type III collagen-platelet interaction: Inhibition by type specific receptor peptides. Thromb Res 2007; 119: 111-9.
5. Siljander PR-M, Farndale RW. Platelet receptors: Collagen. In: Gresele P, Page CP, Fuster V, Vermuylen J, eds Platelets in Thrombotic and Non-Thrombotic Disorders: Pathophysiology, Pharmacology and Therapeutics. Cambridge: Cambridge University Press, 2002: 158-78.
6. Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ. The collagen-binding A-domains of integrin α1β1 and α2β1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem 2000; 275: 35-40.
7. Siljander PR, Hamaia S, Peachey AR, Slatter DA, Smethurst PA, Ouwehand WH, Knight CG, Farndale RW. Integrin activation state determines selectivity for novel recognition sites in fibrillar collagens. J Biol Chem 2004; 279: 47763-72.
8. Raynal N, Hamaia SW, Siljander PR, Maddox B, Peachey AR, Fernandez R, Foley LJ, Slatter DA, Jarvis GE, Farndale RW. Use of synthetic peptides to locate novel integrin alpha2beta1-binding motifs in human collagen III. J Biol Chem 2006; 281: 3821-31.
9. Lisman T, Raynal N, Groeneveld D, Maddox B, Peachey AR, Huizinga EG, de Groot PG, Farndale RW. A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides. Blood 2006; 108: 3753-6.
10. Knight CG, Morton LF, Onley DJ, Peachey AR, Ichinohe T, Okuma M, Farndale RW, Barnes MJ. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet GpVI and mediates platelet activation by collagen. Cardiovasc Res 1999; 41: 450-7.
11. Farndale RW, Siljander PR, Onley DJ, Sundaresan P, Knight CG, Barnes MJ. Collagen-platelet interactions: Recognition and signalling. Biochem Soc Symp 2003; 70: 81-94.
12. Van de Walle GR, Schoolmeester A, Iserbyt BF, Cosemans JM, Heemskerk JW, Hoylaerts MF, Nurden A, Vanhoorelbeke K, Deckmyn H. Activation of alphaIIbbeta3 is a sufficient but also an imperative prerequisite for activation of alpha2beta1 on platelets. Blood 2007; 109: 595-602.
13. Cruz MA, Chen J, Whitelock JL, Morales LD, Lopez JA. The platelet glycoprotein Ib-von Willebrand factor interaction activates the collagen receptor alpha2beta1 to bind collagen: Activation-dependent conformational change of the alpha2-I domain. Blood 2005; 105: 1986-91.
14. Morton LF, Peachey AR, Barnes MJ. Platelet-reactive sites in collagens type I and type III. Evidence for separate adhesion and aggregatory sites. Biochem J 1989; 258: 157-63.
15. Santoro SA, Walsh JJ, Staatz WD, Baranski KJ. Distinct determinants on collagen support alpha 2 beta 1 integrin-mediated platelet adhesion and platelet activation. Cell Regul 1991; 2: 905-13.
16. Sugiyama T, Okuma M, Ushikubi F, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and auto-immune thrombocytopenia. Blood 1987; 69: 1712-20.
17. Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989; 84: 1440-6.
18. Ishibashi T, Ichinohe T, Sugiyama T, Takayama H, Titani K, Okuma M. Functional significance of platelet membrane glycoprotein p62 (GP VI), a putative collagen receptor. Int J Hematol 1995; 62: 107-15.
19. Gibbins JM, Okuma M, Farndale RW, Barnes MJ, Watson SP. Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor γ-chain. FEBS Lett 1997; 413: 255-9.
20. Ichinohe T, Takayama H, Ezumi Y, Arai M, Yamamoto N, Takahashi H, Okuma M. Collagen-stimulated activation of syk but not c-src is severely compromised in human platelets lacking membrane glycoprotein VI. J Biol Chem 1997; 272: 63-8.
21. Kehrel B, Wierwille S, Clemetson KJ, Anders O, Steiner M, Knight CG, Farndale RW, Okuma M, Barnes MJ. Glycoprotein VI is a major collagen receptor for platelet activation: It recognizes the platelet activating quaternary structure of collagen, whereas CD36, GPIIb/IIIa and VWf do not. Blood 1998; 91: 491-9.
22. Santoro SA. Identification of a 160000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 1986; 46: 913-20.
23. Santoro SA, Rajpara SM, Staatz WD, Woods VL Jr. Isolation and characterization of a platelet surface collagen binding complex related to VLA-2. Biochem Biophys Res Commun 1988; 153: 217-23.
24. Nieuwenhuis HK, Sakariassen K, Houdijk WPM, Nievelstein PFEM, Sixma JJ. Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: A defect in platelet spreading. Blood 1986; 68: 692-5.
25. Saelman EUM, Nieuwenhuis HK, Hese KM, de Groot PG, Heijnen HFG, Sage EH, Williams S, McKeown L, Gralnick HR, Sixma JJ. Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (α2β1-integrin). Blood 1994; 83: 1244-50.
26. Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JWM, Zirngibl H, Fassler R. Glycoprotein VI but not alpha 2 beta 1 integrin is essential for platelet interaction with collagen. EMBO J 2001; 20: 2120-30.
27. Chen H, Locke D, Liu Y, Liu C, Kahn ML. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem 2002; 277: 3011-9.
28. Nieuwenhuis HK, Akkerman JWN, Houdijk WPM, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 1985; 318: 470-2.
29. Kehrel B, Balleisen L, Kokott R, Mesters R, Steinziger W, Clemetson KJ, van de Loo J. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 1988; 71: 1074-8.
30. Deckmyn H, Chew SL, Vermylen J. Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia: A novel cause of acquired qualitative platelet dysfunction. Thromb Haemost 1990; 63: 74-9.
31. Siljander PR, Munnix IC, Smethurst PA, Deckmyn H, Lindhout T, Ouwehand WH, Farndale RW, Heemskerk JW. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 2004; 103: 1333-41.
32. Smethurst PA, Joutsi-Korhonen L, O'Connor MN, Wilson E, Jennings NS, Garner SF, Zhang Y, Knight CG, Dafforn TR, Buckle A, Ijsseldijk MJ, De Groot PG, Watkins NA, Farndale RW, Ouwehand WH. Identification of the primary collagen binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody. Blood 2004; 103: 903-11.
33. Andrews RK, Suzuki-Inoue K, Shen Y, Tulasne D, Watson SP, Berndt MC. Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI. Blood 2002; 99: 4219-21.
34. Gardiner EE, Arthur JF, Berndt MC, Andrews RK. Role of calmodulin in platelet receptor function. Curr Med Chem Cardiovasc Hematol Agents 2005; 3: 283-7.
35. Ezumi Y, Shindoh K, Tsuji M, Takayama H. Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets. J Exp Med 1998; 188: 267-76.
36. Suzuki-Inoue K, Tulasne D, Shen Y, Bori-Sanz T, Inoue O, Jung SM, Moroi M, Andrews RK, Berndt MC, Watson SP. Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. J Biol Chem 2002; 277: 21561-6.
37. Sarratt KL, Chen H, Kahn ML, Hammer DA. Platelet receptor glycoprotein VI-mediated adhesion to type I collagen under hydrodynamic flow. Ann Biomed Eng 2004; 32: 970-6.
38. Holtkotter O, Nieswandt B, Smyth N, Muller W, Hafner M, Schulte V, Krieg T, Eckes B. Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 2002; 277: 10789-94.
39. Kuijpers MJ, Schulte V, Bergmeier W, Lindhout T, Brakebusch C, Offermanns S, Fassler R, Heemskerk JW, Nieswandt B. Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo. FASEB J 2003; 17: 685-7.
40. Nieswandt B, Watson SP. Platelet-collagen interaction: Is GPVI the central receptor? Blood 2003; 102: 449-61.
41. Auger JM, Kuijpers MJ, Senis YA, Watson SP, Heemskerk JW. Adhesion of human and mouse platelets to collagen under shear: A unifying model. FASEB J 2005; 19: 825-7.
42. Chen J, Diacovo TG, Grenache DG, Santoro SA, Zutter MM. The alpha(2) integrin subunit-deficient mouse: A multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol 2002; 161: 337-44.
43. Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 2003; 102: 1701-7.
44. Moroi M, Jung SM. A mechanism to safeguard platelet adhesion under high-shear flow: Von Willebrand factor-glycoprotein Ib and integrin alpha2beta1-collagen interactions make compementary, collagen-type-specific contributions to adhesion. J Thromb Haemost 2007; 5: 797-803.
45. Sarratt KL, Chen H, Zutter MM, Santoro SA, Hammer DA, Kahn ML. GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood 2005; 106: 1268-77.
46. Falati S, Edmead CE, Poole AW. Glycoprotein Ib-V-IX, a receptor for von Willebrand Factor, couples physically and functionally to the Fc receptor γ-chain, Fyn, and Lyn to activate human platelets. Blood 1999; 94: 1648-56.
47. Sullam PM, Hyun WC, Szollosi J, Dong J, Foss WM, Lopez JA. Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fc receptor FcgammaRIIA on the platelet plasma membrane. J Biol Chem 1998; 273: 5331-6.
48. Shrimpton CN, Borthakur G, Larrucea S, Cruz MA, Dong JF, Lopez JA. Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation. J Exp Med 2002; 196: 1057-66.
49. Inoue O, Suzuki-Inoue K, Dean WL, Frampton J, Watson SP. Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J Cell Biol 2003; 160: 769-80.
50. Samaha FF, Kahn ML. Novel platelet and vascular roles for immunoreceptor signaling. Arterioscler Thromb Vasc Biol 2006; 26: 2588-93.
51. Gullberg D. I domains in integrins. Georgetown, Texas: Landes Bioscience, 2003.
52. Smith C, Estavillo D, Emsley J, Bankston LA, Liddington RC, Cruz MA. Mapping the Collagen-binding Site in the I. Domain of the Glycoprotein Ia/IIa (Integrin α2β1). J Biol Chem 2000; 275: 4205-9.
53. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. Structural basis of collagen recognition by α2β1. Cell 2000; 101: 47-56.
54. Xu Y, Gurusiddappa S, Rich RL, Owens RT, Keene DR, Mayne R, Hook A, Hook M. Multiple binding sites in collagen type I for the integrins α1β1 and α2β1. J Biol Chem 2000; 275: 38981-9.
55. Farndale RW, Sixma JJ, Barnes MJ, De Groot PG. Role of collagen in thrombosis and haemostasis. J Thromb Haemost 2004; 2: 561-73.
56. Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA, Ouwehand WH, Farndale R, Nieswandt B, Siess W. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 2005; 19: 898-909.
57. Kim JK, Xu Y, Xu X, Keene DR, Gurusiddappa S, Liang X, Wary KK, Hook M. A novel binding site in collagen type III for the integrins, alpha 1 beta 1 and alpha 2 beta 1. J Biol Chem 2005; 280: 32512-20.
58. Chen H, Kahn ML. Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets. Mol Cell Biol 2003; 23: 4764-77.
59. Romijn RA, Bouma B, Wuyster W, Gros P, Kroon J, Sixma JJ, Huizinga EG. Identification of the collagen-binding site of the von Willebrand Factor A3-domain. J Biol Chem 2001; 276: 9985-91.
60. Romijn RA, Westein E, Bouma B, Schiphorst ME, Sixma JJ, Lenting PJ, Huizinga EG. Mapping the collagen-binding site in the von Willebrand factor-A3 domain. J Biol Chem 2003; 278: 15035-9.
61. van der Plas RM, Gomes L, Marquart JA, Vink T, Meijers JC, de Groot PG, Sixma JJ, Huizinga EG. Binding of von Willebrand factor to collagen type III: Role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains. Thromb Haemost 2000; 84: 1005-11.
62. Bonnefoy A, Romijn RA, Vandervoort PA, Vanr I, Vermylen J, Hoylaerts MF. von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen. J Thromb Haemost 2006; 4: 2151-61.
63. Ulrichts H, Udvardy M, Lenting PJ, Pareyn I, Vandeputte N, Vanhoorelbeke K, Deckmyn H. Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. J Biol Chem 2006; 281: 4699-707.
64. Deckmyn H. When collagen meets VWF. Blood 2006; 108: 3628.
65. Clemetson JM, Polgar J, Magnenat E, Wells TNC, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to Fc alpha R and the natural killer receptors. J Biol Chem 1999; 274: 29019-24.
66. Inoue O, Suzuki-Inoue K, McCarty OJ, Moroi M, Ruggeri ZM, Kunicki TJ, Ozaki Y, Watson SP. Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI. Blood 2006; 107: 1405-12.
67. Horii K, Kahn ML, Herr AB. Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI. Blood 2006; 108: 936-42.
68. Lecut C, Arocas V, Ulrichts H, Elbaz A, Villeval JL, Lacapere JJ, Deckmyn H, Jandrot-Perrus M. Identification of residues within human glycoprotein VI involved in the binding to collagen: Evidence for the existence of distinct binding sites. J Biol Chem 2004; 279: 52293-9.
69. O'Connor MN, Smethurst PA, Davies LW, Joutsi-Korhonen L, Onley DJ, Herr AB, Farndale RW, Ouwehand WH. Selective blockade of glycoprotein VI clustering on collagen helices. J Biol Chem 2006; 281: 33505-10.
70. Perret S, Eble JA, Siljander PR, Merle C, Farndale RW, Theisen M, Ruggiero F. Prolyl hydroxylation of collagen type I is required for efficient binding to integrin alpha 1 beta 1 and platelet glycoprotein VI but not to alpha 2 beta 1. J Biol Chem 2003; 278: 29873-9.
71. Smethurst PA, Onley DJ, Jarvis GE, O'Connor MN, Knight CG, Herr AB, Ouwehand WH, Farndale RW. The platelet-collagen interaction: The smallest effective motif for Glycoprotein VI-mediated platelet adhesion and activation contains two Glycine-Proline-Hydroxyproline triplets. J Biol Chem 2006; 000: 000-000.
72. Miura Y, Takahashi T, Jung SM, Moroi M. Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen. J Biol Chem 2002; 277: 46197-204.
73. Ezumi Y, Kodama K, Uchiyama T, Takayama H. Constitutive and functional association of the platelet collagen receptor glycoprotein VI-Fc receptor gamma-chain complex with membrane rafts. Blood 2002; 99: 3250-5.
74. Feng J, Garrity D, Call ME, Moffett H, Wucherpfennig KW. Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors. J Immmunity 2005; 22: 427-38.
75. Asselin J, Knight CG, Farndale RW, Barnes MJ, Watson SP. Monomeric (glycine-proline-hydroxyproline) 10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI. Biochem J 1999; 339: 413-8.
76. Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin α2β11-independent activation of platelets by simple collagen-like peptides: Collagen tertiary (triple helical) structure and quaternary (polymeric) structure are sufficient alone for α2β11-independent platelet reactivity. Biochem J 1995; 306: 337-44.
77. Batuwangala T, Leduc M, Gibbins JM, Bon C, Jones EY. Structure of the snake-venom toxin convulxin. Acta Crystallogr D Biol Crystallogr 2004; 60: 46-53.
78. Kadler KE, Holmes DF, Trotter JA, Chapman JA. Collagen fibril formation. Biochem J 1996; 316: 1-11.
79. Parkinson J, Kadler KE, Brass A. Simple physical model of collagen fibrillogenesis based on diffusion limited aggregation. J Mol Biol 1994; 247: 823-31.
80. Canty EG, Kadler KE. Collagen fibril biosynthesis in tendon: A review and recent insights. Comp Biochem Physiol A Mol Integr Physiol 2002; 133: 979-85.
81. Orgel JP, Irving TC, Miller A, Wess TJ. Microfibrillar structure of type I collagen in situ. Proc Natl Acad Sci USA 2006; 103: 9001-5.
82. Orgel JP, Miller A, Irving TC, Fischetti RF, Hammersley AP, Wess TJ. The in situ supermolecular structure of type I collagen. Structure 2001; 9: 1061-9.
83. Kapyla J, Jaalinoja J, Tulla M, Ylostalo J, Nissinen L, Viitasalo T, Vehvilainen P, Marjomaki V, Nykvist P, Saamanen AM, Farndale RW, Birk DE, Ala-Kokko L, Heino J. The fibril-associated collagen IX provides a novel mechanism for cell adhesion to cartilaginous matrix. J Biol Chem 2004; 279: 51677-87.
84. Guidetti G, Bertoni A, Viola M, Tira E, Balduini C, Torti M. The small proteoglycan decorin supports adhesion and activation of human platelets. Blood 2002; 100: 1707-14.
85. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997; 136: 729-43.
86. Bhide VM, Laschinger CA, Arora PD, Lee W, Hakkinen L, Larjava H, Sodek J, McCulloch CA. Collagen phagocytosis by fibroblasts is regulated by decorin. J Biol Chem 2005; 280: 23103-13.
87. Ruehl M, Somasundaram R, Schoenfelder I, Farndale RW, Knight CG, Schmid M, Ackermann R, Riecken EO, Zeitz M, Schuppan D. The epithelial mitogen keratinocyte growth factor binds to collagens via the consensus sequence glycine-proline-hydroxyproline. J Biol Chem 2002;277: 26872-8.
88. Lebbink RJ, de Ruiter T, Adelmeijer J, Brenkman AB, van Helvoort JM, Koch M, Farndale RW, Lisman T, Sonnenberg A, Lenting PJ, Meyaard L. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 2006; 203: 1419-25.
89. Lopez JA, Del Conde I, Shrimpton CN. Receptors, rafts and microvesicles in thrombosis and inflammation. J Thromb Haemost 2005; 3: 1737-44.
90. Wonerow P, Obergfell A, Wilde JI, Bobe R, Asazuma N, Brdicka T, Leo A, Schraven B, Horejsi V, Shattil SJ, Watson SP. Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets. Biochem J 2002; 364: 755-65.
91. Locke D, Chen H, Liu Y, Liu C, Kahn ML. Lipid rafts orchestrate signaling by the platelet receptor glycoprotein VI. J Biol Chem 2002; 277: 18801-9.
92. Lee FA, van Lier M, Relou IA, Foley L, Akkerman JW, Heijnen HF, Farndale RW. Lipid rafts facilitate the interaction of PECAM-1 with the glycoprotein VI-FcR gamma-chain complex in human platelets. J Biol Chem 2006; 281: 39330-8.
93. Hughan SC, Hughes CE, McCarty OJ, Schweighoffer E, Soultanova I, Ware J, Tybulewicz VL, Watson SP. GPVI potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and Syk. Arterioscler Thromb Vasc Biol 2007; 27: 422-9.
94. Jones KL, Hughan SC, Dopheide SM, Farndale RW, Jackson SP, Jackson DE. Platelet endothelial cell adhesion molecule-1 is a negative regulator of platelet-collagen interactions. Blood 2001; 98: 1456-63.
95. Cicmil M, Thomas JM, Leduc M, Bon C, Gibbins JM. Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets. Blood 2002; 99: 137-44.
96. Thai le M, Ashman LK, Harbour SN, Hogarth PM, Jackson DE. Physical proximity and functional interplay of PECAM-1 with the Fc receptor Fc gamma RIIa on the platelet plasma membrane. Blood 2003; 102: 3637-45.
97. Rathore V, Stapleton MA, Hillery CA, Montgomery RR, Nichols TC, Merricks EP, Newman DK, Newman PJ. PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets. Blood 2003; 102: 3658-64.
98. Arthur JF, Gardiner EE, Matzaris M, Taylor SG, Wijeyewickrema L, Ozaki Y, Kahn ML, Andrews RK, Berndt MC. Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemost 2005; 93: 716-23.
99. van Lier M, Lee F, Farndale RW, Gorter G, Verhoef S, Ohno-Iwashita Y, Akkerman JW, Heijnen HF. Adhesive surface determines raft composition in platelets adhered under flow. J Thromb Haemost 2005; 3: 2514-25.
100. Pietiainen V, Marjomaki V, Upla P, Pelkmans L, Helenius A, Hyypia T. Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol Biol Cell 2004; 15: 4911-25.
101. Bodin S, Soulet C, Tronchere H, Sie P, Gachet C, Plantavid M, Payrastre B. Integrin-dependent interaction of lipid rafts with the actin cytoskeleton in activated human platelets. J Cell Sci 2005; 118: 759-69.
102. Pearce AC, Wonerow P, Marshall SJ, Frampton J, Gartner TK, Watson SP. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa. Biochem J 2004; 378: 193-9.
103. Wee JL, Jackson DE. The Ig-ITIM superfamily member PECAM-1 regulates the 'outside-in' signaling properties of integrin alpha(IIb)beta3 in platelets. Blood 2005; 106: 3816-23.
104. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1: 31-9.
105. Shaw AS. Lipid rafts: Now you see them, now you don't. Nat Immunol 2006; 7: 1139-42.
106. Brownlow SL, Harper AG, Harper MT, Sage SO. A role for hTRPC1 and lipid raft domains in store-mediated calcium entry in human platelets. Cell Calcium 2004; 35: 107-13.
107. Vial C, Fung CY, Goodall AH, Mahaut-Smith MP, Evans RJ. Differential sensitivity of human platelet P2X1 and P2Y1 receptors to disruption of lipid rafts. Biochem Biophys Res Commun 2006; 343: 415-9.
108. 2+ responses of human platelets. Thromb Haemost 2005; 94: 37-40.
109. Quinter PG, Dangelmaier CA, Quinton TM, Kunapuli SP, Daniel JL. Glycoprotein VI agonists have distinct dependences on the lipid raft environment. J Thromb Haemost 2007; 5: 362-8.
110. 1. J Biol Chem 2000; 275: 8016-26.
111. Ratnikov BI, Partridge AW, Ginsberg MH. Integrin activation by talin. J Thromb Haemost 2005; 3: 1783-90.
112. Schoolmeester A, Vanhoorelbeke K, Katsutani S, Depraetere H, Feys HB, Heemskerk JM, Hoylaerts MF, Deckmyn H. Monoclonal antibody IAC-1 is specific for activated alpha2beta1 and binds to amino acids 199 to 201 of the integrin alpha2 I-domain. Blood 2004; 104: 390-6.
113. Van de Walle GR, Vanhoorelbeke K, Majer Z, Illyes E, Baert J, Pareyn I, Deckmyn H. Two functional active conformations of the integrin {alpha}2{beta}1, depending on activation condition and cell type. J Biol Chem 2005; 280: 36873-82.
114. Siljander PR-M, Schoolmeester A, Smerling C, Van de Walle GR, Hamaia S, Deckmyn H, Farndale RW. Functional evidence for three I domain active states for platelet {alpha}2&{beta;}1 integrin. J Thromb Haemost 2005; 3 (Suppl 1): P0935.
115. Lahav J, Wijnen EM, Hess O, Hamaia SW, Griffiths D, Makris M, Knight CG, Essex DW, Farndale RW. Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1. Blood 2003; 102: 2085-92.
116. Bernardi B, Guidetti GF, Campus F, Crittenden JR, Graybiel AM, Balduini C, Torti M. The small GTPase Rap1b regulates the cross talk between platelet integrin alpha2beta1 and integrin alphaIIbbeta3. Blood 2006; 107: 2728-35.